ClinicalTrials.gg
Sign In

Drug

Vipivotide tetraxetan gallium GA-68 clinical trials

Also written 68Ga-PSMA-617.

studies test it
4
open now
3
in phase 3
2
first study started
2020

Keep track of what changes. Save the vipivotide tetraxetan gallium GA-68 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

68Ga-PSMA-617 injection
2

Other names

68Ga-PSMA-617
3

Studies by the year they started

4 studies that test it; most in 2020 (1)

Studies that test vipivotide tetraxetan gallium GA-68, by start year
YearStudies
20201
20211
20221
20241

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 2
2
Phase 3
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Prostatic Neoplasms
4

Who runs them

Industry 0 · Other 4

Peking Union Medical College Hospital (2) · First Affiliated Hospital of Fujian Medical University (1) · Nanjing First Hospital, Nanjing Medical University (1)

Often tested with

Tested in the same studies.

Gallium 68 PSMA-11 (1) · AL18F (1) · 68 Ga-P16-093 (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses vipivotide tetraxetan gallium GA-68 is read from its arms, and is right about nine times in ten.

Testing it · 4

Codes

What other systems call vipivotide tetraxetan gallium GA-68 · ClinicalTrials.gg INT015507

  • UNII (FDA) 7P5C02S4X8VIPIVOTIDE TETRAXETAN GALLIUM GA-68One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.